An introduction to the free radical hypothesis in Parkinson's disease
- 1 January 1992
- journal article
- review article
- Published by Wiley in Annals of Neurology
- Vol. 32 (S1) , S2-S9
- https://doi.org/10.1002/ana.410320703
Abstract
Iron-induced oxidant stress has been implicated in the pathogenesis of Parkinson's disease. An increasing body of evidence now indicates that in Parkinson's disease the environment within the substantia nigra is conducive to the formation of cytotoxic free radicals and cell degeneration. Dopamine neurons may be particularly vulnerable because of the oxidative metabolism of dopamine and the potential of neuromelanin to promote the site-specific accumulation and reduction of iron. This hypothesis has attracted considerable attention because it opens the way for employing antioxidant strategies as possible neuroprotective treatment for Parkinson's disease. Although the concept is appealing, free radicals have not yet been proven to play a role in Parkinson's disease, and many important issues remain to be resolved before the oxidative hypothesis can ultimately be confirmed or refuted.Keywords
This publication has 60 references indexed in Scilit:
- Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridinePublished by Elsevier ,2002
- Chronic dietary pergolide preserves nigrostriatal neuronal integrity in aged-Fischer-344 ratsNeurobiology of Aging, 1992
- Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescenceBiochemical and Biophysical Research Communications, 1990
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- Deficiencies in Complex I subunits of the respiratory chain in Parkinson's diseaseBiochemical and Biophysical Research Communications, 1989
- Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
- Central Mechanisms and Levodopa Response Fluctuations in Parkinsonʼs DiseaseClinical Neuropharmacology, 1988
- Dopamine depletion protects striatal neurons from ischemia-induced cell deathLife Sciences, 1988
- Mitochondrial DNA and human evolutionNature, 1987
- Glutathione peroxidase activity in Parkinson's disease brainNeuroscience Letters, 1985